Oncoclinicas, identified by the ticker symbol ONCO3, announced on Tuesday, April 7, that the chairman of its board of administration, Marcelo Gasparino da Silva, has resigned from his position as a member of the board.
The company noted that because the current board was elected under a multiple voting share system, the resignation of Gasparino results in the removal of the board’s other members as well.
Oncoclinicas stated that the election of new board members will be addressed at an extraordinary general meeting scheduled for April 30, 2026.
In a separate filing also dated April 7, the company reported receiving a nomination from the Mak Capital Fund. The fund put forward four candidates for independent positions on the board of administration: Mateus Affonso Bandeira, Ademar Vidal Neto, Marcos Grodetzky, and Raul Rosenthal Ladeira de Matos. These individuals are set to stand for election at the upcoming extraordinary general meeting.
Mak Capital Fund is a shareholder with a 6.305% stake in the company’s total voting capital.
The structure of corporate boards and the rules governing their election are central to investor oversight of publicly traded companies. Events such as a full board replacement following a single resignation are uncommon and typically stem from specific governance clauses tied to share class voting rights. These situations often lead to a period of transition as shareholders prepare to vote on a new slate of directors nominated by major stakeholders or other investor groups.
- Brazil Market Update: Key Firms in Focus - abril 7, 2026
- Brazil’s Oncoclínicas (ONCO3) Board Chairman Quits - abril 7, 2026
- Brazil stocks, dollar and corporate news in focus - abril 7, 2026
